Emily Field News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer of GSK Plc found her remedy in a product almost 60 years in the making.Most Read from BloombergHims Debuts $199 Weight-Loss Shots at 85% Discount to WegovyIran State TV Says ‘No Sign of Life’ at Helicopter Crash SiteJamie Dimon Says Succession at JPMorgan Is ‘Well on the Way’One of the Last Big Bears on Wall Street Turns Bullish on US StocksFlorida’s 125% Surge in Property-

AstraZeneca aims for a 75% revenue boost to $80 billion by 2030, driven by 20 new medicines and growth in existing portfolios. CEO Pascal Soriot has revitalized the drug pipeline with key blockbusters. Analysts anticipate key insights at today's investor day event.

Miramichi is now considering modifying its Sunday shopping bylaw, allowing business owners to set their own hours, after a request from the Retail Council of Canada. The city is the last in New Brunswick to maintain restrictions on Sunday shopping.

Already positive, the research from Barclays and its analyst Emily Field still consider the stock as a Buy opportunity. The target price is slightly modified from 200 to 205 EUR.

A former world record holder was on hand to crown the winner of the Bourton Mile.